Literature DB >> 27255530

[Bilateral retinal detachment].

C Melzer1, F G Holz2, S Schmitz-Valckenberg2.   

Abstract

Mesh：

Year:  2017        PMID： 27255530     DOI： 10.1007/s00347-016-0277-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  9 in total

1.  Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or "ecstasy".

Authors:  L Hassan; C Carvalho; L A Yannuzzi; T Iida; S Negrão
Journal:  Retina       Date:  2001       Impact factor: 4.256

Review 2.  Central serous chorioretinopathy and glucocorticoids.

Authors:  Evrydiki A Bouzas; Panagiotis Karadimas; Constantin J Pournaras
Journal:  Surv Ophthalmol       Date:  2002 Sep-Oct       Impact factor: 6.048

Review 3.  Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Authors:  S M Berman; R Kuczenski; J T McCracken; E D London
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

4.  Endocrine abnormalities in patients with central serous chorioretinopathy.

Authors:  Robert Haimovici; Shimon Rumelt; James Melby
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

5.  Indocyanine green videoangiography of older patients with central serous chorioretinopathy.

Authors:  R F Spaide; L Hall; A Haas; L Campeas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Retina       Date:  1996       Impact factor: 4.256

Review 6.  Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.

Authors:  Andrew J Kleinberger; Chirag Patel; Ronni M Lieberman; Benjamin D Malkin
Journal:  Laryngoscope       Date:  2011-08-16       Impact factor: 3.325

7.  Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.

Authors:  R Haimovici; E S Gragoudas; J S Duker; R N Sjaarda; D Eliott
Journal:  Ophthalmology       Date:  1997-10       Impact factor: 12.079

8.  Central serous chorioretinopathy associated with administration of sympathomimetic agents.

Authors:  John C Michael; John Pak; Jose Pulido; Guillermo de Venecia
Journal:  Am J Ophthalmol       Date:  2003-07       Impact factor: 5.258

9.  Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings.

Authors:  H Yoshioka; Y Katsume; H Akune
Journal:  Ophthalmologica       Date:  1982       Impact factor: 3.250
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.